trial · primary record
NKX019
Systemic Sclerosis
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 240 |
| Primary completion | 2028-10 |
| Primary endpoint | Incidence of Dose-limiting toxicities (DLTs) [Safety and Tolerability] |
| Registry ID | NCT06733935 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:14.889Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06733935
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.